Dark Forest Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
25,950
-28,204
| -52% | -$1.23M | 0.05% | 692 |
|
|
2025
Q1 | $1.48M | Buy |
54,154
+43,905
| +428% | +$1.2M | 0.07% | 495 |
|
|
2024
Q4 | $412K | Buy |
10,249
+5,839
| +132% | +$235K | 0.06% | 525 |
|
|
2024
Q3 | $209K | Buy |
+4,410
| New | +$209K | 0.03% | 852 |
|
|
2023
Q4 | – | Sell |
-36,698
| Closed | -$510K | – | 809 |
|
|
2023
Q3 | $510K | Buy |
36,698
+17,280
| +89% | +$240K | 0.04% | 710 |
|
|
2023
Q2 | $446K | Buy |
19,418
+11,376
| +141% | +$262K | 0.04% | 673 |
|
|
2023
Q1 | $238K | Buy |
+8,042
| New | +$238K | 0.06% | 315 |
|
|
2022
Q4 | – | Sell |
-267
| Closed | -$6K | – | 1330 |
|
|
2022
Q3 | $6K | Sell |
267
-231
| -46% | -$5.19K | ﹤0.01% | 847 |
|
|
2022
Q2 | $10K | Buy |
498
+425
| +582% | +$8.53K | ﹤0.01% | 526 |
|
|
2022
Q1 | $3K | Buy |
73
+4
| +6% | +$164 | ﹤0.01% | 1147 |
|
|
2021
Q4 | $4K | Sell |
69
-779
| -92% | -$45.2K | ﹤0.01% | 1227 |
|
|
2021
Q3 | $50K | Buy |
848
+823
| +3,292% | +$48.5K | 0.02% | 564 |
|
|
2021
Q2 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 784 |
|